Muscle ultrasonography shows high diagnostic accuracy for fasciculation detection in ALS

This systematic review and meta-analysis evaluated the diagnostic accuracy of muscle ultrasonography (MUS) for detecting fasciculations in amyotrophic lateral sclerosis (ALS). The analysis synthesized data from 13 studies involving a total of 1,176 participants. The study setting was not reported, and the analysis did not specify whether studies were prospective or retrospective. The population consisted of patients undergoing evaluation for ALS, though specific demographic characteristics and disease stages were not detailed in the meta-analysis. The comparator was not explicitly reported, though the analysis inherently compared MUS findings to a reference standard for ALS diagnosis, typically involving clinical and electrodiagnostic criteria.

The intervention was muscle ultrasonography specifically for fasciculation detection. The meta-analysis did not report specific technical parameters, transducer frequencies, or muscle groups examined across the included studies. The primary outcome was the diagnostic accuracy of MUS for detecting fasciculations in ALS, with results presented as pooled estimates. The pooled sensitivity was 0.87 (95% CI 0.83-0.91), and the pooled specificity was 0.91 (95% CI 0.86-0.94). The pooled positive likelihood ratio was 9.81 (95% CI 6.25-15.40), and the pooled negative likelihood ratio was 0.14 (95% CI 0.10-0.19). The diagnostic odds ratio was 70.03 (95% CI 41.72-117.56), and the area under the summary receiver operating characteristic (SROC) curve was 0.94 (95% CI 0.91-0.95).

Key secondary outcomes included post-test probability calculations. At a pre-test probability of 30%, the post-test probability after a positive MUS result was 81%, while the post-test probability after a negative MUS result was 6%. These calculations demonstrate how MUS findings can substantially alter diagnostic probability in clinical practice. The meta-analysis did not report other secondary outcomes such as inter-rater reliability, cost-effectiveness, or impact on diagnostic delay.

Safety and tolerability findings were not reported in this meta-analysis. The included studies did not provide data on adverse events, serious adverse events, discontinuations, or patient discomfort associated with MUS procedures. This represents a significant gap in the evidence, though MUS is generally considered a non-invasive imaging technique with minimal risk.

These results represent the most comprehensive synthesis to date on MUS for fasciculation detection in ALS. Prior studies have demonstrated the feasibility of MUS but with variable accuracy estimates. This meta-analysis provides more precise estimates by pooling data across multiple studies, confirming that MUS has high diagnostic accuracy comparable to some electrodiagnostic techniques for fasciculation detection. The area under the SROC curve of 0.94 indicates excellent overall diagnostic performance.

Key methodological limitations include the lack of reported details about individual study designs, patient populations, and MUS protocols. The meta-analysis did not report limitations of the included studies, though heterogeneity in MUS techniques and operator experience likely exists. The analysis detected no significant publication bias (p=0.61), but scan duration was identified as a factor influencing accuracy, with scans ≥30 seconds associated with higher sensitivity but relatively lower specificity based on meta-regression. The absence of safety data and detailed protocol information limits clinical application.

Clinical implications suggest MUS may serve as a useful adjunct to electrodiagnostic evaluation in ALS diagnosis. The high sensitivity and specificity support its potential role in detecting fasciculations, particularly when electromyography is unavailable, contraindicated, or poorly tolerated. The post-test probability calculations provide practical guidance for interpreting MUS results in clinical contexts. However, MUS should not replace comprehensive clinical and electrodiagnostic evaluation, as ALS diagnosis requires meeting established diagnostic criteria beyond fasciculation detection alone.

Unanswered questions include the optimal MUS protocol (muscle selection, scanning duration, transducer frequency), the diagnostic accuracy in early versus advanced ALS, the performance compared to needle electromyography across different muscle groups, and the impact on diagnostic timelines and patient outcomes. Future studies should standardize MUS protocols, include safety and tolerability assessments, and evaluate MUS in prospective diagnostic algorithms alongside conventional diagnostic methods.